News & Analysis as of

Continuing Resolution Food and Drug Administration (FDA) Congressional Committees

Akin Gump Strauss Hauer & Feld LLP

Five Health Care Issues to Watch as Congress Returns from August Recess

Health care is a consistently active area for policymakers on Capitol Hill. This alert highlights five health policy issues to watch as Congress returns from August recess. While the fiscal year 2026 (FY26) appropriations...more

Holland & Knight LLP

Holland & Knight Health Dose: January 24, 2024

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide